TSMNX
Price
$16.07
Change
-$0.10 (-0.62%)
Updated
Sep 20 closing price
VSCPX
Price
$326.54
Change
-$2.23 (-0.68%)
Updated
Sep 20 closing price
Ad is loading...

TSMNX vs VSCPX

Header iconTSMNX vs VSCPX Comparison
Open Charts TSMNX vs VSCPXBanner chart's image
Nuveen Quant Small/Mid Cap Eq I
Price$16.07
Change-$0.10 (-0.62%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index InstlPlus
Price$326.54
Change-$2.23 (-0.68%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TSMNX vs VSCPX Comparison Chart
Loading...
VS
TSMNX vs. VSCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TSMNX is a StrongBuy and VSCPX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 149B vs. TSMNX (1.38B). VSCPX pays higher dividends than TSMNX: VSCPX (1.44) vs TSMNX (0.82). TSMNX was incepted earlier than VSCPX: TSMNX (8 years) vs VSCPX (14 years). TSMNX is a more actively managed with annual turnover of: 86.00 vs. VSCPX (12.00). TSMNX has a lower initial minimum investment than VSCPX: TSMNX (100000) vs VSCPX (100000000). TSMNX annual gain was more profitable for investors over the last year : 24.85 vs. VSCPX (20.76). VSCPX return over 5 years is better than : 51.88 vs. TSMNX (34.13).
TSMNXVSCPXTSMNX / VSCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years14 years-
Gain YTD14.0809.741145%
Front LoadN/AN/A-
Min. Initial Investment1000001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B149B1%
Annual Yield % from dividends0.821.4457%
Returns for 1 year24.8520.76120%
Returns for 3 years-7.695.72-135%
Returns for 5 years34.1351.8866%
Returns for 10 yearsN/A114.22-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGTX25.250.17
+0.68%
TG Therapeutics
SMID36.830.21
+0.57%
Smith-Midland Corp
NTR46.82-0.08
-0.17%
Nutrien Ltd
REX44.81-0.63
-1.39%
REX American Resources Corp
SABS2.56-0.21
-7.58%
SAB Biotherapeutics